1h Free Analyst Time
SummarySpeak directly to the analyst to clarify any post sales queries you may have.
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H2 2020, provides an overview of the Melanoma (Oncology) pipeline landscape.
Melanoma is a tumor that develops as a result of the malignant transformation of melanocytes. These cells are derived from the neural crest. Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. In women, the most common site is the legs and melanomas in men are most common on the back. Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels are sign of melanoma. Treatment includes surgery, radiation and proton therapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Melanoma - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Melanoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 25, 182, 209, 2, 13, 297, 40 and 4 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 2, 25, 20, 86 and 12 molecules, respectively.
Melanoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Melanoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Melanoma (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Melanoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Melanoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
IntroductionMelanoma - Overview
Melanoma - Therapeutics Development
Melanoma - Therapeutics Assessment
Melanoma - Companies Involved in Therapeutics Development
Melanoma - Drug Profiles
Melanoma - Dormant Projects
Melanoma - Discontinued Products
Melanoma - Product Development Milestones
Appendix
List of Tables
- Number of Products under Development for Melanoma, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Products under Development by Companies, H2 2020
- Products under Development by Universities/Institutes, H2 2020
- Number of Products by Stage and Target, H2 2020
- Number of Products by Stage and Mechanism of Action, H2 2020
- Number of Products by Stage and Route of Administration, H2 2020
- Number of Products by Stage and Molecule Type, H2 2020
- Melanoma - Pipeline by 4D Pharma Plc, H2 2020
- Melanoma - Pipeline by 4SC AG, H2 2020
- Melanoma - Pipeline by 7 Hills Pharma LLC, H2 2020
- Melanoma - Pipeline by AbbVie Inc, H2 2020
- Melanoma - Pipeline by Abcuro Inc, H2 2020
- Melanoma - Pipeline by Abion Inc, H2 2020
- Melanoma - Pipeline by Abivax SA, H2 2020
- Melanoma - Pipeline by ABM Therapeutics Inc, H2 2020
- Melanoma - Pipeline by AC Bioscience SA, H2 2020
- Melanoma - Pipeline by Accendatech Co Ltd, H2 2020
- Melanoma - Pipeline by Accuitis Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Acepodia Biotech Inc, H2 2020
- Melanoma - Pipeline by ACF Pharmaceuticals LLC, H2 2020
- Melanoma - Pipeline by Achilles Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Actym Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Adaptimmune Therapeutics Plc, H2 2020
- Melanoma - Pipeline by Adare Pharma Solutions, H2 2020
- Melanoma - Pipeline by ADC Therapeutics SA, H2 2020
- Melanoma - Pipeline by Adicet Bio Inc, H2 2020
- Melanoma - Pipeline by Adjuvance Technologies Inc, H2 2020
- Melanoma - Pipeline by Adlai Nortye Biopharma Co Ltd, H2 2020
- Melanoma - Pipeline by Advanced BioDesign, H2 2020
- Melanoma - Pipeline by Advantageous Systems LLC, H2 2020
- Melanoma - Pipeline by Advenchen Laboratories LLC, H2 2020
- Melanoma - Pipeline by Aeglea BioTherapeutics Inc, H2 2020
- Melanoma - Pipeline by Afecta Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Affichem SA, H2 2020
- Melanoma - Pipeline by AgenTus Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Agenus Inc, H2 2020
- Melanoma - Pipeline by AGV Discovery SAS, H2 2020
- Melanoma - Pipeline by AIM ImmunoTech Inc, H2 2020
- Melanoma - Pipeline by AIMM Therapeutics BV, H2 2020
- Melanoma - Pipeline by AiVita Biomedical Inc, H2 2020
- Melanoma - Pipeline by Akeso Inc, H2 2020
- Melanoma - Pipeline by Alkermes Plc, H2 2020
- Melanoma - Pipeline by Allarity Therapeutics A/S, H2 2020
- Melanoma - Pipeline by Allergy Therapeutics Plc, H2 2020
- Melanoma - Pipeline by Alligator Bioscience AB, H2 2020
- Melanoma - Pipeline by AlphaMab Co Ltd, H2 2020
- Melanoma - Pipeline by Alphamab Oncology, H2 2020
- Melanoma - Pipeline by ALS Biopharma LLC, H2 2020
- Melanoma - Pipeline by Altor Bioscience LLC, H2 2020
- Melanoma - Pipeline by Amgen Inc, H2 2020
- Melanoma - Pipeline by Anaveon AG, H2 2020
- Melanoma - Pipeline by Andes Biotechnologies, H2 2020
- Melanoma - Pipeline by AnGes Inc, H2 2020
- Melanoma - Pipeline by Antengene Corp, H2 2020
- Melanoma - Pipeline by AntiCancer Inc, H2 2020
- Melanoma - Pipeline by APEIRON Biologics AG, H2 2020
- Melanoma - Pipeline by Apexian Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Apexigen Inc, H2 2020
- Melanoma - Pipeline by Aphios Corp, H2 2020
- Melanoma - Pipeline by APO-T BV, H2 2020
- Melanoma - Pipeline by Apogenix AG, H2 2020
- Melanoma - Pipeline by Apollomics Inc, H2 2020
- Melanoma - Pipeline by Arcus Biosciences Inc, H2 2020
- Melanoma - Pipeline by Ardan Pharma, H2 2020
- Melanoma - Pipeline by Arisaph Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Asana BioSciences LLC, H2 2020
- Melanoma - Pipeline by Ascentage Pharma Group International, H2 2020
- Melanoma - Pipeline by Astex Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by AstraZeneca Plc, H2 2020
- Melanoma - Pipeline by Athenex Inc, H2 2020
- Melanoma - Pipeline by Atreca Inc, H2 2020
- Melanoma - Pipeline by aTyr Pharma Inc, H2 2020
- Melanoma - Pipeline by Aurigene Discovery Technologies Ltd, H2 2020
- Melanoma - Pipeline by Autolus Therapeutics Plc, H2 2020
- Melanoma - Pipeline by Avalia Immunotherapies Ltd, H2 2020
- Melanoma - Pipeline by AVAX Technologies Inc, H2 2020
- Melanoma - Pipeline by Avidin Biotechnology Ltd, H2 2020
- Melanoma - Pipeline by Avotres Inc, H2 2020
- Melanoma - Pipeline by Bantam Pharmaceutical LLC, H2 2020
- Melanoma - Pipeline by Barricade Therapeutics Corp, H2 2020
- Melanoma - Pipeline by Batu Biologics Inc, H2 2020
- Melanoma - Pipeline by Bayer AG, H2 2020
- Melanoma - Pipeline by BeiGene Ltd, H2 2020
- Melanoma - Pipeline by Beijing Kawin Technology Share-Holding Co Ltd, H2 2020
- Melanoma - Pipeline by Beijing Neoantigen Biotechnology Co Ltd, H2 2020
- Melanoma - Pipeline by BerGenBio ASA, H2 2020
- Melanoma - Pipeline by Bessor Pharma LLC, H2 2020
- Melanoma - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2020
- Melanoma - Pipeline by Binjiang Pharma, Inc., H2 2020
- Melanoma - Pipeline by Bio-Cancer Treatment International Ltd, H2 2020
- Melanoma - Pipeline by Bio-Thera Solutions Ltd, H2 2020
- Melanoma - Pipeline by BioAtla LLC, H2 2020
- Melanoma - Pipeline by Biocad, H2 2020
- Melanoma - Pipeline by Biogazelle NV, H2 2020
- Melanoma - Pipeline by Biogen Inc, H2 2020
- Melanoma - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2020
- Melanoma - Pipeline by BioInvent International AB, H2 2020
- Melanoma - Pipeline by BioLineRx Ltd, H2 2020
- Melanoma - Pipeline by BioMed Valley Discoveries Inc, H2 2020
- Melanoma - Pipeline by Bionomics Ltd, H2 2020
- Melanoma - Pipeline by BioNTech SE, H2 2020
- Melanoma - Pipeline by Bioquark Inc, H2 2020
- Melanoma - Pipeline by Biosion Inc, H2 2020
- Melanoma - Pipeline by BioVaxys Technology Corp, H2 2020
- Melanoma - Pipeline by Biovista Inc, H2 2020
- Melanoma - Pipeline by BioXcel Therapeutics Inc, H2 2020
- Melanoma - Pipeline by BJ Bioscience Inc, H2 2020
- Melanoma - Pipeline by Boehringer Ingelheim International GmbH, H2 2020
- Melanoma - Pipeline by BriaCell Therapeutics Corp, H2 2020
- Melanoma - Pipeline by BridgeBio Pharma Inc, H2 2020
- Melanoma - Pipeline by BrightPath Biotherapeutics Co Ltd, H2 2020
- Melanoma - Pipeline by Bristol-Myers Squibb Co, H2 2020
- Melanoma - Pipeline by Bromodomain Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Byondis BV, H2 2020
- Melanoma - Pipeline by Calidi Biotherapeutics Inc, H2 2020
- Melanoma - Pipeline by Calithera Biosciences Inc, H2 2020
- Melanoma - Pipeline by Can-Fite BioPharma Ltd, H2 2020
- Melanoma - Pipeline by Cancure Ltd, H2 2020
- Melanoma - Pipeline by Cantargia AB, H2 2020
- Melanoma - Pipeline by CDR-Life Inc, H2 2020
- Melanoma - Pipeline by Celdara Medical LLC, H2 2020
- Melanoma - Pipeline by Celldex Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Cellestia Biotech AG, H2 2020
- Melanoma - Pipeline by Cellid Co Ltd, H2 2020
- Melanoma - Pipeline by Celprogen Inc, H2 2020
- Melanoma - Pipeline by Centurion BioPharma Corp, H2 2020
- Melanoma - Pipeline by Checkmate Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Checkpoint Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Chineo Med Beijing Co Ltd, H2 2020
- Melanoma - Pipeline by Chinook Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2020
- Melanoma - Pipeline by Cloaked Therapeutics LLC, H2 2020
- Melanoma - Pipeline by Codagenix Inc, H2 2020
- Melanoma - Pipeline by Codiak BioSciences Inc, H2 2020
- Melanoma - Pipeline by CohBar Inc, H2 2020
- Melanoma - Pipeline by Constellation Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Convalife, H2 2020
- Melanoma - Pipeline by Corvus Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by CStone Pharmaceuticals Co Ltd, H2 2020
- Melanoma - Pipeline by Cue Biopharma Inc, H2 2020
- Melanoma - Pipeline by Cura Therapeutics LLC, H2 2020
- Melanoma - Pipeline by Curebiotech Inc, H2 2020
- Melanoma - Pipeline by CureLab Oncology Inc, H2 2020
- Melanoma - Pipeline by Curevac AG, H2 2020
- Melanoma - Pipeline by Cynata Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Cytocom Inc, H2 2020
- Melanoma - Pipeline by Cytodyn Inc, H2 2020
- Melanoma - Pipeline by CytoTools AG, H2 2020
- Melanoma - Pipeline by CytoVac AS, H2 2020
- Melanoma - Pipeline by CyTuVax BV, H2 2020
- Melanoma - Pipeline by CZ BioMed Corp, H2 2020
- Melanoma - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
- Melanoma - Pipeline by DC4U BV, H2 2020
- Melanoma - Pipeline by Debiopharm International SA, H2 2020
- Melanoma - Pipeline by Deciphera Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by DEKK-TEC Inc, H2 2020
- Melanoma - Pipeline by Dicerna Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by DNAtrix Inc, H2 2020
- Melanoma - Pipeline by Domain Therapeutics SA, H2 2020
- Melanoma - Pipeline by Dracen Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Dragonfly Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Eisai Co Ltd, H2 2020
- Melanoma - Pipeline by Eli Lilly and Co, H2 2020
- Melanoma - Pipeline by Ella Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Emcure Pharmaceuticals Ltd, H2 2020
- Melanoma - Pipeline by ENB Therapeutics LLC, H2 2020
- Melanoma - Pipeline by EnGeneIC Ltd, H2 2020
- Melanoma - Pipeline by EntreChem SL, H2 2020
- Melanoma - Pipeline by Epigene Therapeutics Inc, H2 2020
- Melanoma - Pipeline by EpimAb Biotherapeutics Inc, H2 2020
- Melanoma - Pipeline by Epizyme Inc, H2 2020
- Melanoma - Pipeline by Epsilogen Ltd, H2 2020
- Melanoma - Pipeline by Ervaxx Ltd, H2 2020
- Melanoma - Pipeline by Eternity Bioscience Inc, H2 2020
- Melanoma - Pipeline by eTheRNA Immunotherapies NV, H2 2020
- Melanoma - Pipeline by Eucure (Beijing) Biopharma Co Ltd, H2 2020
- Melanoma - Pipeline by Eutilex Co Ltd, H2 2020
- Melanoma - Pipeline by Evaxion Biotech ApS, H2 2020
- Melanoma - Pipeline by Evelo Biosciences Inc, H2 2020
- Melanoma - Pipeline by EVOQ Therapeutics LLC, H2 2020
- Melanoma - Pipeline by Evotec SE, H2 2020
- Melanoma - Pipeline by Exelixis Inc, H2 2020
- Melanoma - Pipeline by Exicure Inc, H2 2020
- Melanoma - Pipeline by F. Hoffmann-La Roche Ltd, H2 2020
- Melanoma - Pipeline by Faron Pharmaceuticals Oy, H2 2020
- Melanoma - Pipeline by Fate Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Five Prime Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Flow Pharma Inc, H2 2020
- Melanoma - Pipeline by Fochon Pharmaceutical Ltd, H2 2020
- Melanoma - Pipeline by Galderma SA, H2 2020
- Melanoma - Pipeline by Galectin Therapeutics Inc, H2 2020
- Melanoma - Pipeline by GEEN Biotechnology Inc, H2 2020
- Melanoma - Pipeline by Genelux Corp, H2 2020
- Melanoma - Pipeline by Genemedicine Ltd, H2 2020
- Melanoma - Pipeline by Genentech USA Inc, H2 2020
- Melanoma - Pipeline by Generium, H2 2020
- Melanoma - Pipeline by Genexine Inc, H2 2020
- Melanoma - Pipeline by Genmab AS, H2 2020
- Melanoma - Pipeline by Genocea Biosciences Inc, H2 2020
- Melanoma - Pipeline by GigaGen Inc, H2 2020
- Melanoma - Pipeline by Gilead Sciences Inc, H2 2020
- Melanoma - Pipeline by GlaxoSmithKline Plc, H2 2020
- Melanoma - Pipeline by GLG Pharma SA, H2 2020
- Melanoma - Pipeline by GlycoNex Inc, H2 2020
- Melanoma - Pipeline by Gmax Biopharm Ltd, H2 2020
- Melanoma - Pipeline by GNT Biotech and Medicals Corp, H2 2020
- Melanoma - Pipeline by Gradalis Inc, H2 2020
- Melanoma - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H2 2020
- Melanoma - Pipeline by Guangzhou FineImmune Biotechnology Co Ltd, H2 2020
- Melanoma - Pipeline by Guangzhou Hanghua Bio Pharmaceutical Technology Co, H2 2020
- Melanoma - Pipeline by HaimBio Ltd, H2 2020
- Melanoma - Pipeline by Hangzhou Neoantigen Therapeutics Co Ltd, H2 2020
- Melanoma - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2020
- Melanoma - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H2 2020
- Melanoma - Pipeline by Harbour BioMed, H2 2020
- Melanoma - Pipeline by Heat Biologics Inc, H2 2020
- Melanoma - Pipeline by Hengenix Biotech Inc, H2 2020
- Melanoma - Pipeline by Hercules Pharmaceuticals BV, H2 2020
- Melanoma - Pipeline by Hibercell Inc, H2 2020
- Melanoma - Pipeline by Highlight Therapeutics SL, H2 2020
- Melanoma - Pipeline by HitGen Inc, H2 2020
- Melanoma - Pipeline by Hookipa Pharma Inc, H2 2020
- Melanoma - Pipeline by Horizon Therapeutics Plc, H2 2020
- Melanoma - Pipeline by Hualan Biological Engineering Inc, H2 2020
- Melanoma - Pipeline by HylaPharm, H2 2020
- Melanoma - Pipeline by Ideaya Biosciences Inc, H2 2020
- Melanoma - Pipeline by Idera Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Ikena Oncology Inc, H2 2020
- Melanoma - Pipeline by ImCheck Therapeutics SAS, H2 2020
- Melanoma - Pipeline by Immatics NV, H2 2020
- Melanoma - Pipeline by Immodulon Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by ImmuneSensor Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Immunetune BV, H2 2020
- Melanoma - Pipeline by ImmunityBio Inc, H2 2020
- Melanoma - Pipeline by Immunocore Ltd, H2 2020
- Melanoma - Pipeline by Immunophotonics Inc, H2 2020
- Melanoma - Pipeline by ImmunoRestoration Inc, H2 2020
- Melanoma - Pipeline by Immunos Therapeutics AG, H2 2020
- Melanoma - Pipeline by ImmunSYS Inc, H2 2020
- Melanoma - Pipeline by Immutep Ltd, H2 2020
- Melanoma - Pipeline by Immvira Co Ltd, H2 2020
- Melanoma - Pipeline by Imugene Ltd, H2 2020
- Melanoma - Pipeline by Incuron LLC, H2 2020
- Melanoma - Pipeline by Incyte Corp, H2 2020
- Melanoma - Pipeline by Infinity Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by IngenoVax LLC, H2 2020
- Melanoma - Pipeline by Inhibrx Inc, H2 2020
- Melanoma - Pipeline by Inmune Bio Inc, H2 2020
- Melanoma - Pipeline by Innate Pharma SA, H2 2020
- Melanoma - Pipeline by Inner Mongolia Qite Biotechnology (Group) Co Ltd, H2 2020
- Melanoma - Pipeline by InnoBioPharma LLC, H2 2020
- Melanoma - Pipeline by Innovent Biologics Inc, H2 2020
- Melanoma - Pipeline by Innovimmune Biotherapeutics Inc, H2 2020
- Melanoma - Pipeline by Inovactis SAS, H2 2020
- Melanoma - Pipeline by Inovio Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Instil Bio UK Ltd, H2 2020
- Melanoma - Pipeline by IntelliStem Technologies Inc, H2 2020
- Melanoma - Pipeline by Intensity Therapeutics Inc, H2 2020
- Melanoma - Pipeline by InterK Peptide Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by InteRNA Technologies BV, H2 2020
- Melanoma - Pipeline by InxMed Shanghai Co Ltd, H2 2020
- Melanoma - Pipeline by IO Biotech ApS, H2 2020
- Melanoma - Pipeline by iOnctura SA, H2 2020
- Melanoma - Pipeline by Iovance Biotherapeutics Inc, H2 2020
- Melanoma - Pipeline by iOx Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by ISOThrive Inc, H2 2020
- Melanoma - Pipeline by Istari Oncology Inc, H2 2020
- Melanoma - Pipeline by ISU ABXIS Co Ltd, H2 2020
- Melanoma - Pipeline by iTeos Therapeutics Inc, H2 2020
- Melanoma - Pipeline by JHL Biotech Inc, H2 2020
- Melanoma - Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, H2 2020
- Melanoma - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2020
- Melanoma - Pipeline by Jiangsu Sinorda Biomedicine Co Ltd, H2 2020
- Melanoma - Pipeline by Johnson & Johnson, H2 2020
- Melanoma - Pipeline by Jounce Therapeutics Inc, H2 2020
- Melanoma - Pipeline by JS InnoPharm (Shanghai) Ltd, H2 2020
- Melanoma - Pipeline by Jubilant Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Karus Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Karyopharm Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Kine Sciences, H2 2020
- Melanoma - Pipeline by Kineta Inc, H2 2020
- Melanoma - Pipeline by Kinnate Biopharma Inc, H2 2020
- Melanoma - Pipeline by Kitov Pharma Ltd, H2 2020
- Melanoma - Pipeline by Kolon Life Science Inc, H2 2020
- Melanoma - Pipeline by Komipharm International Co Ltd, H2 2020
- Melanoma - Pipeline by Kringle Pharma Inc, H2 2020
- Melanoma - Pipeline by Kuur Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Kymab Ltd, H2 2020
- Melanoma - Pipeline by Laboratorio Pablo Cassara SRL, H2 2020
- Melanoma - Pipeline by Latima SIA, H2 2020
- Melanoma - Pipeline by Learmont Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Leidos Health, H2 2020
- Melanoma - Pipeline by Lentigen Technology Inc, H2 2020
- Melanoma - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, H2 2020
- Melanoma - Pipeline by Ligand Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Light Chain Bioscience, H2 2020
- Melanoma - Pipeline by Linnaeus Therapeutics Inc, H2 2020
- Melanoma - Pipeline by LintonPharm Co Ltd, H2 2020
- Melanoma - Pipeline by Lipo-Immuno Tech LLC, H2 2020
- Melanoma - Pipeline by Lixte Biotechnology Holdings Inc, H2 2020
- Melanoma - Pipeline by Lokon Pharma AB, H2 2020
- Melanoma - Pipeline by Luye Pharma Group Ltd, H2 2020
- Melanoma - Pipeline by Lytix Biopharma AS, H2 2020
- Melanoma - Pipeline by Lyvgen Biopharma Ltd, H2 2020
- Melanoma - Pipeline by MacroGenics Inc, H2 2020
- Melanoma - Pipeline by MAIA Biotechnology Inc, H2 2020
- Melanoma - Pipeline by Mateon Therapeutics Inc, H2 2020
- Melanoma - Pipeline by MaxiVAX SA, H2 2020
- Melanoma - Pipeline by MediaPharma SRL, H2 2020
- Melanoma - Pipeline by Medicenna Therapeutics Corp, H2 2020
- Melanoma - Pipeline by MediciNova Inc, H2 2020
- Melanoma - Pipeline by MediGene AG, H2 2020
- Melanoma - Pipeline by Mediolanum farmaceutici SpA, H2 2020
- Melanoma - Pipeline by MedPacto Inc, H2 2020
- Melanoma - Pipeline by Mekanistic Therapeutics LLC, H2 2020
- Melanoma - Pipeline by MELEMA Pharma GmbH, H2 2020
- Melanoma - Pipeline by Merck & Co Inc, H2 2020
- Melanoma - Pipeline by Merck KGaA, H2 2020
- Melanoma - Pipeline by Meryx Inc, H2 2020
- Melanoma - Pipeline by MetabloQ Pty Ltd, H2 2020
- Melanoma - Pipeline by MGC Pharmaceuticals Ltd, H2 2020
- Melanoma - Pipeline by Microbiotica Ltd, H2 2020
- Melanoma - Pipeline by Millennium Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Miltenyi Biotec BV & Co KG, H2 2020
- Melanoma - Pipeline by Mirata Biopharma LLC, H2 2020
- Melanoma - Pipeline by Mirati Therapeutics Inc, H2 2020
- Melanoma - Pipeline by MiReven Pty Ltd, H2 2020
- Melanoma - Pipeline by Mirrx Therapeutics A/S, H2 2020
- Melanoma - Pipeline by Moderna Inc, H2 2020
- Melanoma - Pipeline by Molecular Partners AG, H2 2020
- Melanoma - Pipeline by Molecular Templates Inc, H2 2020
- Melanoma - Pipeline by Moleculin Biotech Inc, H2 2020
- Melanoma - Pipeline by Morphogenesis Inc, H2 2020
- Melanoma - Pipeline by Mosaic ImmunoEngineering Inc, H2 2020
- Melanoma - Pipeline by Multitude therapeutics Inc, H2 2020
- Melanoma - Pipeline by MultiVir Inc, H2 2020
- Melanoma - Pipeline by MyeloRx LLC, H2 2020
- Melanoma - Pipeline by Nanjing Jinsirui Biotechnology Co Ltd, H2 2020
- Melanoma - Pipeline by NantBioScience Inc, H2 2020
- Melanoma - Pipeline by Nektar Therapeutics, H2 2020
- Melanoma - Pipeline by Neoleukin Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Neonc Technologies Inc, H2 2020
- Melanoma - Pipeline by NeoTX Therapeutics Ltd, H2 2020
- Melanoma - Pipeline by Neumedicines Inc, H2 2020
- Melanoma - Pipeline by New Amsterdam Sciences Inc, H2 2020
- Melanoma - Pipeline by NewG Lab Pharma Inc, H2 2020
- Melanoma - Pipeline by NexImmune Inc, H2 2020
- Melanoma - Pipeline by NextCure Inc, H2 2020
- Melanoma - Pipeline by NGM Biopharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Ningbo Wenda Pharma, H2 2020
- Melanoma - Pipeline by Nirogyone Therapeutics LLC, H2 2020
- Melanoma - Pipeline by Northwest Biotherapeutics Inc, H2 2020
- Melanoma - Pipeline by Novartis AG, H2 2020
- Melanoma - Pipeline by Noxopharm Ltd, H2 2020
- Melanoma - Pipeline by Nubiyota LLC, H2 2020
- Melanoma - Pipeline by Numab Therapeutics AG, H2 2020
- Melanoma - Pipeline by Nynex Therapeutics LLC, H2 2020
- Melanoma - Pipeline by Ocuphire Pharma Inc, H2 2020
- Melanoma - Pipeline by OliPass Corporation, H2 2020
- Melanoma - Pipeline by Omeros Corp, H2 2020
- Melanoma - Pipeline by Ona Therapeutics SL, H2 2020
- Melanoma - Pipeline by OncoArendi Therapeutics SA, H2 2020
- Melanoma - Pipeline by OncoImmune Inc, H2 2020
- Melanoma - Pipeline by Oncology Research International Ltd, H2 2020
- Melanoma - Pipeline by Oncolys BioPharma Inc, H2 2020
- Melanoma - Pipeline by Onconova Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Oncorus Inc, H2 2020
- Melanoma - Pipeline by OncoSec Medical Inc, H2 2020
- Melanoma - Pipeline by OncoTartis Inc, H2 2020
- Melanoma - Pipeline by Oncotelic Inc, H2 2020
- Melanoma - Pipeline by Oncovir Inc, H2 2020
- Melanoma - Pipeline by Oneness Biotech Co Ltd, H2 2020
- Melanoma - Pipeline by OnKure Inc, H2 2020
- Melanoma - Pipeline by Ono Pharmaceutical Co Ltd, H2 2020
- Melanoma - Pipeline by Orbis Health Solutions LLC, H2 2020
- Melanoma - Pipeline by OrienGene Biotechnology Ltd, H2 2020
- Melanoma - Pipeline by Orpheus Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Oxford BioTherapeutics Ltd, H2 2020
- Melanoma - Pipeline by Pacific Northwest Biotechnology LLC, H2 2020
- Melanoma - Pipeline by Pact Pharma Inc, H2 2020
- Melanoma - Pipeline by Paranta Biosciences Ltd, H2 2020
- Melanoma - Pipeline by Partner Therapeutics Inc, H2 2020
- Melanoma - Pipeline by PCI Biotech Holding ASA, H2 2020
- Melanoma - Pipeline by PDC Line Pharma SAS, H2 2020
- Melanoma - Pipeline by PDS Biotechnology Corp, H2 2020
- Melanoma - Pipeline by PDX Pharmaceuticals LLC, H2 2020
- Melanoma - Pipeline by PepVax Inc, H2 2020
- Melanoma - Pipeline by Pfizer Inc, H2 2020
- Melanoma - Pipeline by Pharmaxis Ltd, H2 2020
- Melanoma - Pipeline by Philogen SpA, H2 2020
- Melanoma - Pipeline by Phio Pharmaceuticals Corp, H2 2020
- Melanoma - Pipeline by Phoenix Life Sciences International Ltd, H2 2020
- Melanoma - Pipeline by PHusis Therapeutics Inc, H2 2020
- Melanoma - Pipeline by Pieris Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Pionyr Immunotherapeutics Inc, H2 2020
- Melanoma - Pipeline by Plexxikon Inc, H2 2020
- Melanoma - Pipeline by Plus Therapeutics Inc, H2 2020
- Melanoma - Pipeline by PokeAcell, H2 2020
- Melanoma - Pipeline by Polaris Pharmaceuticals Inc, H2 2020
- Melanoma - Pipeline by Polynoma LLC, H2 2020
- Melanoma - Pipeline by Polyplus-Transfection SA, H2 2020
- Melanoma - Pipeline by Prestige BioPharma Pte Ltd, H2 2020
- Melanoma - Pipeline by Primevax Immuno Oncology Inc, H2 2020
- Melanoma - Pipeline by PRISM Pharma Co Ltd, H2 2020
- Melanoma - Pipeline by Processa Pharmaceuticals Inc, H2 2020
List of Figures
- Number of Products under Development for Melanoma, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Number of Products by Top 10 Targets, H2 2020
- Number of Products by Stage and Top 10 Targets, H2 2020
- Number of Products by Top 10 Mechanism of Actions, H2 2020
- Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
- Number of Products by Top 10 Routes of Administration, H2 2020
- Number of Products by Stage and Top 10 Routes of Administration, H2 2020
- Number of Products by Top 10 Molecule Types, H2 2020
- Number of Products by Stage and Top 10 Molecule Types, H2 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4D Pharma Plc
- 4SC AG
- 7 Hills Pharma LLC
- AbbVie Inc
- Abcuro Inc
- Abion Inc
- Abivax SA
- ABM Therapeutics Inc
- AC Bioscience SA
- Accendatech Co Ltd
- Accuitis Pharmaceuticals Inc
- Acepodia Biotech Inc
- ACF Pharmaceuticals LLC
- Achilles Therapeutics Ltd
- Actym Therapeutics Inc
- Adaptimmune Therapeutics Plc
- Adare Pharma Solutions
- ADC Therapeutics SA
- Adicet Bio Inc
- Adjuvance Technologies Inc
- Adlai Nortye Biopharma Co Ltd
- Advanced BioDesign
- Advantageous Systems LLC
- Advenchen Laboratories LLC
- Aeglea BioTherapeutics Inc
- Afecta Pharmaceuticals Inc
- Affichem SA
- AgenTus Therapeutics Inc
- Agenus Inc
- AGV Discovery SAS
- AIM ImmunoTech Inc
- AIMM Therapeutics BV
- AiVita Biomedical Inc
- Akeso Inc
- Alkermes Plc
- Allarity Therapeutics A/S
- Allergy Therapeutics Plc
- Alligator Bioscience AB
- AlphaMab Co Ltd
- Alphamab Oncology
- ALS Biopharma LLC
- Altor Bioscience LLC
- Amgen Inc
- Anaveon AG
- Andes Biotechnologies
- AnGes Inc
- Antengene Corp
- AntiCancer Inc
- APEIRON Biologics AG
- Apexian Pharmaceuticals Inc
- Apexigen Inc
- Aphios Corp
- APO-T BV
- Apogenix AG
- Apollomics Inc
- Arcus Biosciences Inc
- Ardan Pharma
- Arisaph Pharmaceuticals Inc
- Asana BioSciences LLC
- Ascentage Pharma Group International
- Astex Pharmaceuticals Inc
- AstraZeneca Plc
- Athenex Inc
- Atreca Inc
- aTyr Pharma Inc
- Aurigene Discovery Technologies Ltd
- Autolus Therapeutics Plc
- Avalia Immunotherapies Ltd
- AVAX Technologies Inc
- Avidin Biotechnology Ltd
- Avotres Inc
- Bantam Pharmaceutical LLC
- Barricade Therapeutics Corp
- Batu Biologics Inc
- Bayer AG
- BeiGene Ltd
- Beijing Kawin Technology Share-Holding Co Ltd
- Beijing Neoantigen Biotechnology Co Ltd
- BerGenBio ASA
- Bessor Pharma LLC
- Betta Pharmaceuticals Co Ltd
- Binjiang Pharma, Inc.
- Bio-Cancer Treatment International Ltd
- Bio-Thera Solutions Ltd
- BioAtla LLC
- Biocad
- Biogazelle NV
- Biogen Inc
- Biohaven Pharmaceutical Holding Company Ltd
- BioInvent International AB
- BioLineRx Ltd
- BioMed Valley Discoveries Inc
- Bionomics Ltd
- BioNTech SE
- Bioquark Inc
- Biosion Inc
- BioVaxys Technology Corp
- Biovista Inc
- BioXcel Therapeutics Inc
- BJ Bioscience Inc
- Boehringer Ingelheim International GmbH
- BriaCell Therapeutics Corp
- BridgeBio Pharma Inc
- BrightPath Biotherapeutics Co Ltd
- Bristol-Myers Squibb Co
- Bromodomain Pharmaceuticals Inc
- Byondis BV
- Calidi Biotherapeutics Inc
- Calithera Biosciences Inc
- Can-Fite BioPharma Ltd
- Cancure Ltd
- Cantargia AB
- CDR-Life Inc
- Celdara Medical LLC
- Celldex Therapeutics Inc
- Cellestia Biotech AG
- Cellid Co Ltd
- Celprogen Inc
- Centurion BioPharma Corp
- Checkmate Pharmaceuticals Inc
- Checkpoint Therapeutics Inc
- Chineo Med Beijing Co Ltd
- Chinook Therapeutics Inc
- Chugai Pharmaceutical Co Ltd
- Cloaked Therapeutics LLC
- Codagenix Inc
- Codiak BioSciences Inc
- CohBar Inc
- Constellation Pharmaceuticals Inc
- Convalife
- Corvus Pharmaceuticals Inc
- CStone Pharmaceuticals Co Ltd
- Cue Biopharma Inc
- Cura Therapeutics LLC
- Curebiotech Inc
- CureLab Oncology Inc
- Curevac AG
- Cynata Therapeutics Ltd
- Cytocom Inc
- Cytodyn Inc
- CytoTools AG
- CytoVac AS
- CyTuVax BV
- CZ BioMed Corp
- Daiichi Sankyo Co Ltd
- DC4U BV
- Debiopharm International SA
- Deciphera Pharmaceuticals Inc
- DEKK-TEC Inc
- Dicerna Pharmaceuticals Inc
- DNAtrix Inc
- Domain Therapeutics SA
- Dracen Pharmaceuticals Inc
- Dragonfly Therapeutics Inc
- Eisai Co Ltd
- Eli Lilly and Co
- Ella Therapeutics Ltd
- Emcure Pharmaceuticals Ltd
- ENB Therapeutics LLC
- EnGeneIC Ltd
- EntreChem SL
- Epigene Therapeutics Inc
- EpimAb Biotherapeutics Inc
- Epizyme Inc
- Epsilogen Ltd
- Ervaxx Ltd
- Eternity Bioscience Inc
- eTheRNA Immunotherapies NV
- Eucure (Beijing) Biopharma Co Ltd
- Eutilex Co Ltd
- Evaxion Biotech ApS
- Evelo Biosciences Inc
- EVOQ Therapeutics LLC
- Evotec SE
- Exelixis Inc
- Exicure Inc
- F. Hoffmann-La Roche Ltd
- Faron Pharmaceuticals Oy
- Fate Therapeutics Inc
- Five Prime Therapeutics Inc
- Flow Pharma Inc
- Fochon Pharmaceutical Ltd
- Galderma SA
- Galectin Therapeutics Inc
- GEEN Biotechnology Inc
- Genelux Corp
- Genemedicine Ltd
- Genentech USA Inc
- Generium
- Genexine Inc
- Genmab AS
- Genocea Biosciences Inc
- GigaGen Inc
- Gilead Sciences Inc
- GlaxoSmithKline Plc
- GLG Pharma SA
- GlycoNex Inc
- Gmax Biopharm Ltd
- GNT Biotech and Medicals Corp
- Gradalis Inc
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou FineImmune Biotechnology Co Ltd
- Guangzhou Hanghua Bio Pharmaceutical Technology Co
- HaimBio Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harbour BioMed
- Heat Biologics Inc
- Hengenix Biotech Inc
- Hercules Pharmaceuticals BV
- Hibercell Inc
- Highlight Therapeutics SL
- HitGen Inc
- Hookipa Pharma Inc
- Horizon Therapeutics Plc
- Hualan Biological Engineering Inc
- HylaPharm
- Ideaya Biosciences Inc
- Idera Pharmaceuticals Inc
- Ikena Oncology Inc
- ImCheck Therapeutics SAS
- Immatics NV
- Immodulon Therapeutics Ltd
- ImmuneSensor Therapeutics Inc
- Immunetune BV
- ImmunityBio Inc
- Immunocore Ltd
- Immunophotonics Inc
- ImmunoRestoration Inc
- Immunos Therapeutics AG
- ImmunSYS Inc
- Immutep Ltd
- Immvira Co Ltd
- Imugene Ltd
- Incuron LLC
- Incyte Corp
- Infinity Pharmaceuticals Inc
- IngenoVax LLC
- Inhibrx Inc
- Inmune Bio Inc
- Innate Pharma SA
- Inner Mongolia Qite Biotechnology (Group) Co Ltd
- InnoBioPharma LLC
- Innovent Biologics Inc
- Innovimmune Biotherapeutics Inc
- Inovactis SAS
- Inovio Pharmaceuticals Inc
- Instil Bio UK Ltd
- IntelliStem Technologies Inc
- Intensity Therapeutics Inc
- InterK Peptide Therapeutics Ltd
- InteRNA Technologies BV
- InxMed Shanghai Co Ltd
- IO Biotech ApS
- iOnctura SA
- Iovance Biotherapeutics Inc
- iOx Therapeutics Ltd
- ISOThrive Inc
- Istari Oncology Inc
- ISU ABXIS Co Ltd
- iTeos Therapeutics Inc
- JHL Biotech Inc
- Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Sinorda Biomedicine Co Ltd
- Johnson & Johnson
- Jounce Therapeutics Inc
- JS InnoPharm (Shanghai) Ltd
- Jubilant Therapeutics Inc
- Karus Therapeutics Ltd
- Karyopharm Therapeutics Inc
- Kine Sciences
- Kineta Inc
- Kinnate Biopharma Inc
- Kitov Pharma Ltd
- Kolon Life Science Inc
- Komipharm International Co Ltd
- Kringle Pharma Inc
- Kuur Therapeutics Ltd
- Kymab Ltd
- Laboratorio Pablo Cassara SRL
- Latima SIA
- Learmont Pharmaceuticals Inc
- Leidos Health
- Lentigen Technology Inc
- Lepu Medical Technology (Beijing) Co Ltd
- Ligand Pharmaceuticals Inc
- Light Chain Bioscience
- Linnaeus Therapeutics Inc
- LintonPharm Co Ltd
- Lipo-Immuno Tech LLC
- Lixte Biotechnology Holdings Inc
- Lokon Pharma AB
- Luye Pharma Group Ltd
- Lytix Biopharma AS
- Lyvgen Biopharma Ltd
- MacroGenics Inc
- MAIA Biotechnology Inc
- Mateon Therapeutics Inc
- MaxiVAX SA
- MediaPharma SRL
- Medicenna Therapeutics Corp
- MediciNova Inc
- MediGene AG
- Mediolanum farmaceutici SpA
- MedPacto Inc
- Mekanistic Therapeutics LLC
- MELEMA Pharma GmbH
- Merck & Co Inc
- Merck KGaA
- Meryx Inc
- MetabloQ Pty Ltd
- MGC Pharmaceuticals Ltd
- Microbiotica Ltd
- Millennium Pharmaceuticals Inc
- Miltenyi Biotec BV & Co KG
- Mirata Biopharma LLC
- Mirati Therapeutics Inc
- MiReven Pty Ltd
- Mirrx Therapeutics A/S
- Moderna Inc
- Molecular Partners AG
- Molecular Templates Inc
- Moleculin Biotech Inc
- Morphogenesis Inc
- Mosaic ImmunoEngineering Inc
- Multitude therapeutics Inc
- MultiVir Inc
- MyeloRx LLC
- Nanjing Jinsirui Biotechnology Co Ltd
- NantBioScience Inc
- Nektar Therapeutics
- Neoleukin Therapeutics Inc
- Neonc Technologies Inc
- NeoTX Therapeutics Ltd
- Neumedicines Inc
- New Amsterdam Sciences Inc
- NewG Lab Pharma Inc
- NexImmune Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- Ningbo Wenda Pharma
- Nirogyone Therapeutics LLC
- Northwest Biotherapeutics Inc
- Novartis AG
- Noxopharm Ltd
- Nubiyota LLC
- Numab Therapeutics AG
- Nynex Therapeutics LLC
- Ocuphire Pharma Inc
- OliPass Corporation
- Omeros Corp
- Ona Therapeutics SL
- OncoArendi Therapeutics SA
- OncoImmune Inc
- Oncology Research International Ltd
- Oncolys BioPharma Inc
- Onconova Therapeutics Inc
- Oncorus Inc
- OncoSec Medical Inc
- OncoTartis Inc
- Oncotelic Inc
- Oncovir Inc
- Oneness Biotech Co Ltd
- OnKure Inc
- Ono Pharmaceutical Co Ltd
- Opsona Therapeutics Ltd
- Orbis Health Solutions LLC
- OrienGene Biotechnology Ltd
- Orpheus Therapeutics Inc
- Oxford BioTherapeutics Ltd
- Pacific Northwest Biotechnology LLC
- Pact Pharma Inc
- Paranta Biosciences Ltd
- Partner Therapeutics Inc
- PCI Biotech Holding ASA
- PDC Line Pharma SAS
- PDS Biotechnology Corp
- PDX Pharmaceuticals LLC
- PepVax Inc
- Pfizer Inc
- Pharmaxis Ltd
- Philogen SpA
- Phio Pharmaceuticals Corp
- Phoenix Life Sciences International Ltd
- PHusis Therapeutics Inc
- Pieris Pharmaceuticals Inc
- Pionyr Immunotherapeutics Inc
- Plexxikon Inc
- Plus Therapeutics Inc
- PokeAcell
- Polaris Pharmaceuticals Inc
- Polynoma LLC
- Polyplus-Transfection SA
- Prestige BioPharma Pte Ltd
- Primevax Immuno Oncology Inc
- PRISM Pharma Co Ltd
- Processa Pharmaceuticals Inc
- Promore Pharma AB
- Propanc Biopharma Inc
- Protheragen Inc
- Provectus Biopharmaceuticals Inc
- Provenance Biopharmaceuticals Corp
- Puma Biotechnology Inc
- Puretech Health Plc
- PYCTX Ltd
- QBiotics Ltd
- Qilu Puget Sound Biotherapeutics Corp
- Qu Biologics Inc
- Quadriga BioSciences Inc
- RadImmune Therapeutics Inc
- Reata Pharmaceuticals Inc
- Recombio SL
- Regeneron Pharmaceuticals Inc
- Resonant Therapeutics Inc
- RetroVirox Inc
- Reven Pharmaceuticals Inc
- RHEACELL GmbH & Co KG
- Rubicon Biotechnology Inc
- Rubius Therapeutics Inc
- Salarius Pharmaceuticals Inc
- SANOCHEMIA Pharmazeutika GmbH
- Sanofi
- Sapience Therapeutics Inc
- SATT Nord
- Scancell Holdings Plc
- Scholar Rock Inc
- Scopus BioPharma Inc
- Seagen Inc
- Seres Therapeutics Inc
- Seven and Eight Biopharmaceuticals Corp
- Shandong Taize Huikang Biomedical Co Ltd
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Hycharm Inc
- Shanghai Junshi Bioscience Co Ltd
- Shattuck Labs Inc
- Shenogen Pharma Group Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shouyao Holding Co Ltd
- Sichuan Haisco Pharmaceutical Co Ltd
- Sichuan Huiyang Life Science and Technology Corp
- SilaGene Inc
- Sillajen Biotherapeutics
- Sino Biopharmaceutical Ltd
- Sirnaomics Inc
- Sonnet BioTherapeutics Holdings Inc
- Sonoval LLC
- Sotio AS
- Spring Bank Pharmaceuticals Inc
- SpringWorks Therapeutics Inc
- Sprint Bioscience AB
- Starwise Therapeutics LLC
- STAT3 Therapeutics Inc
- Stcube Inc
- Stella Pharmaceuticals Pvt Ltd
- Sumitomo Dainippon Pharma Co Ltd
- Sumitomo Dainippon Pharma Oncology, Inc
- Suntec Medical (Taiwan) Inc
- Susavion Biosciences Inc
- SuviCa Inc
- Suzhou Everhealth Biomedical Co Ltd
- Suzhou Maximum Bio-tech Co Ltd
- Syndivia SAS
- Synthis LLC
- Syntrix Biosystems Inc
- Systimmune Inc
- Tactical Therapeutics Inc
- Tactiva Therapeutics LLC
- TAE Life Sciences LLC
- Taiga Biotechnologies Inc
- TaiRx Inc
- Takara Bio Inc
- Takis Srl
- Targovax ASA
- TCR Cure Biopharma Technology Co Ltd
- Telesis Therapeutics LLC
- Tevogen Bio Inc
- TheraPten Biosciences Inc
- Theratechnologies Inc
- Theravectys SA
- Tidal Therapeutics Inc
- Tikcro Technologies Ltd
- TILT Biotherapeutics Ltd
- Timmune Biotech Inc
- Tmunity Therapeutics Inc
- Tollbridge Therapeutics LLC
- Torque Therapeutics Inc
- Transcode Therapeutics Inc
- Treadwell Therapeutics Inc
- TREAT U SA
- Treos Bio Ltd
- Turning Point Therapeutics Inc
- Turnstone Biologics Inc
- Tvardi Therapeutics Inc
- TVAX Biomedical Inc
- UBI Pharma Inc
- UbiVac LLC
- Ultimovacs AS
- Vaccinex Inc
- Vacthera BioTech GmbH
- Valo Therapeutics Oy
- Vascular Biogenics Ltd
- Vault Pharma Inc
- Vaxess Technologies Inc
- Vaxil Bio Therapeutics Ltd
- Veana Therapeutics LLC
- Vedanta Biosciences Inc
- Verastem Inc
- VerImmune Inc
- Veru Inc
- Vichem Chemie Research Ltd
- Viewpoint Molecular Targeting LLC
- Viralytics Pty Ltd
- Virocure Inc
- ViruCure Therapeutics Ltd
- VM Discovery Inc
- VREX Therapeutics Inc
- Vyriad Inc
- WntResearch AB
- Wuhan Binhui Biotechnology Co Ltd
- Wuhan YZY Biopharma Co Ltd
- X4 Pharmaceuticals Inc
- Xbrane Biopharma AB
- Xcovery Holding Co LLC
- XEME BioPharma Inc
- Xencor Inc
- Xiangxue Life Sciences
- Xynomic Pharmaceuticals Holdings Inc
- Y-Biologics Inc
- Y-mAbs Therapeutics Inc
- Yooyoung Pharm Co Ltd
- Yukin Therapeutics SAS
- Zelluna Immunotherapy AS
- Zhejiang Teruisi Pharmaceutical Co Ltd
- Zhejiang Yangshengtang Biotech Co Ltd
